1 2490 87 YOGA AS AN INTERVENTION TO MANAGE MULTIPLE SCLEROSIS SYMPTOMS. MULTIPLE SCLEROSIS (MS) IS AN AUTOIMMUNE, DEMYELINATING, INFLAMMATORY DISEASE OF CENTRAL NERVOUS SYSTEM (CNS) WHICH IS CHARACTERIZED BY SPASTICITY, FATIGUE, DEPRESSION, ANXIETY, BOWEL AND BLADDER DYSFUNCTION, IMPAIRED MOBILITY, COGNITIVE IMPAIRMENT ETC. AND AFFECTS APPROXIMATELY 2.5 MILLION PEOPLE WORLDWIDE. DISEASE MODIFYING THERAPIES FOR MS WHICH HELP IN PREVENTING ACCUMULATION OF LESIONS IN WHITE MATTER OF CNS ARE COSTLY AND HAVE SIGNIFICANT ADVERSE EFFECTS. THEREFORE, PATIENTS WITH MS ARE USING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND YOGA IS ONE OF THE MOST POPULAR FORM OF CAM WHICH IS BEING USED IMMENSELY TO REDUCE OR OVERCOME THE SYMPTOMS OF MS. IN THE CURRENT REVIEW ATTEMPTED TO PRESENT THE POTENTIAL IMPACT OF YOGA PRACTICES ON REDUCING MS RELATED SYMPTOMS. 2020 2 2636 32 YOGA FOR TREATING URINARY INCONTINENCE IN WOMEN. BACKGROUND: URINARY INCONTINENCE IN WOMEN IS ASSOCIATED WITH POOR QUALITY OF LIFE AND DIFFICULTIES IN SOCIAL, PSYCHOLOGICAL AND SEXUAL FUNCTIONING. THE CONDITION MAY AFFECT UP TO 15% OF MIDDLE-AGED OR OLDER WOMEN IN THE GENERAL POPULATION. CONSERVATIVE TREATMENTS SUCH AS LIFESTYLE INTERVENTIONS, BLADDER TRAINING AND PELVIC FLOOR MUSCLE TRAINING (USED EITHER ALONE OR IN COMBINATION WITH OTHER INTERVENTIONS) ARE THE INITIAL APPROACHES TO THE MANAGEMENT OF URINARY INCONTINENCE. MANY WOMEN ARE INTERESTED IN ADDITIONAL TREATMENTS SUCH AS YOGA, A SYSTEM OF PHILOSOPHY, LIFESTYLE AND PHYSICAL PRACTICE THAT ORIGINATED IN ANCIENT INDIA. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA FOR TREATING URINARY INCONTINENCE IN WOMEN. SEARCH METHODS: WE SEARCHED THE COCHRANE INCONTINENCE AND COCHRANE COMPLEMENTARY MEDICINE SPECIALISED REGISTERS. WE SEARCHED THE WORLD HEALTH ORGANIZATION INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM (WHO ICTRP) AND CLINICALTRIALS.GOV TO IDENTIFY ANY ONGOING OR UNPUBLISHED STUDIES. WE HANDSEARCHED PROCEEDINGS OF THE INTERNATIONAL CONGRESS ON COMPLEMENTARY MEDICINE RESEARCH AND THE EUROPEAN CONGRESS FOR INTEGRATIVE MEDICINE. WE SEARCHED THE NHS ECONOMIC EVALUATION DATABASE FOR ECONOMIC STUDIES, AND SUPPLEMENTED THIS SEARCH WITH SEARCHES FOR ECONOMICS STUDIES IN MEDLINE AND EMBASE FROM 2015 ONWARDS. DATABASE SEARCHES ARE UP-TO-DATE AS OF 21 JUNE 2018. SELECTION CRITERIA: RANDOMISED CONTROLLED TRIALS IN WOMEN DIAGNOSED WITH URINARY INCONTINENCE IN WHICH ONE GROUP WAS ALLOCATED TO TREATMENT WITH YOGA. DATA COLLECTION AND ANALYSIS: TWO REVIEW AUTHORS INDEPENDENTLY SCREENED TITLES AND ABSTRACTS OF ALL RETRIEVED ARTICLES, SELECTED STUDIES FOR INCLUSION, EXTRACTED DATA, ASSESSED RISK OF BIAS AND EVALUATED THE CERTAINTY OF THE EVIDENCE FOR EACH REPORTED OUTCOME. ANY DISAGREEMENTS WERE RESOLVED BY CONSENSUS. WE PLANNED TO COMBINE CLINICALLY COMPARABLE STUDIES IN REVIEW MANAGER 5 USING RANDOM-EFFECTS META-ANALYSIS AND TO CARRY OUT SENSITIVITY AND SUBGROUP ANALYSES. WE PLANNED TO CREATE A TABLE LISTING ECONOMIC STUDIES ON YOGA FOR INCONTINENCE BUT NOT CARRY OUT ANY ANALYSES ON THESE STUDIES. MAIN RESULTS: WE INCLUDED TWO STUDIES (INVOLVING A TOTAL OF 49 WOMEN). EACH STUDY COMPARED YOGA TO A DIFFERENT COMPARATOR, THEREFORE WE WERE UNABLE TO COMBINE THE DATA IN A META-ANALYSIS. A THIRD STUDY THAT HAS BEEN COMPLETED BUT NOT YET FULLY REPORTED IS AWAITING ASSESSMENT.ONE INCLUDED STUDY WAS A SIX-WEEK STUDY COMPARING YOGA TO A WAITING LIST IN 19 WOMEN WITH EITHER URGENCY URINARY INCONTINENCE OR STRESS URINARY INCONTINENCE. WE JUDGED THE CERTAINTY OF THE EVIDENCE FOR ALL REPORTED OUTCOMES AS VERY LOW DUE TO PERFORMANCE BIAS, DETECTION BIAS, AND IMPRECISION. THE NUMBER OF WOMEN REPORTING CURE WAS NOT REPORTED. WE ARE UNCERTAIN WHETHER YOGA RESULTS IN SATISFACTION WITH CURE OR IMPROVEMENT OF INCONTINENCE (RISK RATIO (RR) 6.33, 95% CONFIDENCE INTERVAL (CI) 1.44 TO 27.88; AN INCREASE OF 592 FROM 111 PER 1000, 95% CI 160 TO 1000). WE ARE UNCERTAIN WHETHER THERE IS A DIFFERENCE BETWEEN YOGA AND WAITING LIST IN CONDITION-SPECIFIC QUALITY OF LIFE AS MEASURED ON THE INCONTINENCE IMPACT QUESTIONNAIRE SHORT FORM (MEAN DIFFERENCE (MD) 1.74, 95% CI -33.02 TO 36.50); THE NUMBER OF MICTURITIONS (MD -0.77, 95% CI -2.13 TO 0.59); THE NUMBER OF INCONTINENCE EPISODES (MD -1.57, 95% CI -2.83 TO -0.31); OR THE BOTHERSOMENESS OF INCONTINENCE AS MEASURED ON THE UROGENITAL DISTRESS INVENTORY 6 (MD -0.90, 95% CI -1.46 TO -0.34). THERE WAS NO EVIDENCE OF A DIFFERENCE IN THE NUMBER OF WOMEN WHO EXPERIENCED AT LEAST ONE ADVERSE EVENT (RISK DIFFERENCE 0%, 95% CI -38% TO 38%; NO DIFFERENCE FROM 222 PER 1000, 95% CI 380 FEWER TO 380 MORE).THE SECOND INCLUDED STUDY WAS AN EIGHT-WEEK STUDY IN 30 WOMEN WITH URGENCY URINARY INCONTINENCE THAT COMPARED MINDFULNESS-BASED STRESS REDUCTION (MBSR) TO AN ACTIVE CONTROL INTERVENTION OF YOGA CLASSES. THE STUDY WAS UNBLINDED, AND THERE WAS HIGH ATTRITION FROM BOTH STUDY ARMS FOR ALL OUTCOME ASSESSMENTS. WE JUDGED THE CERTAINTY OF THE EVIDENCE FOR ALL REPORTED OUTCOMES AS VERY LOW DUE TO PERFORMANCE BIAS, ATTRITION BIAS, IMPRECISION AND INDIRECTNESS. THE NUMBER OF WOMEN REPORTING CURE WAS NOT REPORTED. WE ARE UNCERTAIN WHETHER WOMEN IN THE YOGA GROUP WERE LESS LIKELY TO REPORT IMPROVEMENT IN INCONTINENCE AT EIGHT WEEKS COMPARED TO WOMEN IN THE MBSR GROUP (RR 0.09, 95% CI 0.01 TO 1.43; A DECREASE OF 419 FROM 461 PER 1000, 95% CI 5 TO 660). WE ARE UNCERTAIN ABOUT THE EFFECT OF MBSR COMPARED TO YOGA ON REPORTS OF CURE OR IMPROVEMENT IN INCONTINENCE, IMPROVEMENT IN CONDITION-SPECIFIC QUALITY OF LIFE MEASURED ON THE OVERACTIVE BLADDER HEALTH-RELATED QUALITY OF LIFE SCALE, REDUCTION IN INCONTINENCE EPISODES OR REDUCTION IN BOTHERSOMENESS OF INCONTINENCE AS MEASURED ON THE OVERACTIVE BLADDER SYMPTOM AND QUALITY OF LIFE-SHORT FORM AT EIGHT WEEKS. THE STUDY DID NOT REPORT ON ADVERSE EFFECTS. AUTHORS' CONCLUSIONS: WE IDENTIFIED FEW TRIALS ON YOGA FOR INCONTINENCE, AND THE EXISTING TRIALS WERE SMALL AND AT HIGH RISK OF BIAS. IN ADDITION, WE DID NOT FIND ANY STUDIES OF ECONOMIC OUTCOMES RELATED TO YOGA FOR URINARY INCONTINENCE. DUE TO THE LACK OF EVIDENCE TO ANSWER THE REVIEW QUESTION, WE ARE UNCERTAIN WHETHER YOGA IS USEFUL FOR WOMEN WITH URINARY INCONTINENCE. ADDITIONAL, WELL-CONDUCTED TRIALS WITH LARGER SAMPLE SIZES ARE NEEDED. 2019 3 1482 14 INTEGRATING YOGA THERAPY IN THE MANAGEMENT OF URINARY INCONTINENCE: A CASE REPORT. A 63-YEAR-OLD OVERWEIGHT FEMALE PREDIAGNOSED OF STRESS URINARY INCONTINENCE PRESENTED WITH EXACERBATED EVENTS OF URINE LEAKAGE. SHE WAS ADVISED A RESIDENTIAL LIFESTYLE AND BEHAVIORAL PROGRAM, PRIMARILY CONSISTING OF A MONITORED YOGA THERAPY MODULE, APART FROM HER ONGOING ANTICHOLINERGIC MEDICINE, FOR 21 DAYS. ASSESSMENTS WERE BASED ON A FREQUENCY VOLUME CHART, A BLADDER DIARY FOR THE ENTIRE DURATION OF TREATMENT, AND THE INTERNATIONAL CONSULTATION ON INCONTINENCE MODULAR QUESTIONNAIRE-URINARY INCONTINENCE SHORT FORM QUESTIONNAIRE ON THE DAYS OF ADMISSION AND DISCHARGE. A TOTAL OF 1.9 KG OF WEIGHT LOSS WAS OBSERVED DURING HER STAY. USAGE OF PAD, AS REPORTED IN HER DIARY, REDUCED FROM 3 TO 1 PER DAY. HER INTERNATIONAL CONSULTATION ON INCONTINENCE MODULAR QUESTIONNAIRE-URINARY INCONTINENCE SHORT FORM SCORE REDUCED FROM 16 TO 9, INDICATING BETTER CONTINENCE. SHE EXPRESSED SUBJECTIVE WELL-BEING AND CONFIDENCE IN HER SOCIAL INTERACTIONS. THIS IS PROBABLY THE FIRST CASE REPORT DEMONSTRATING FEASIBILITY OF INTEGRATION OF YOGA THERAPY IN THE MANAGEMENT OF URINARY INCONTINENCE. 2015 4 2273 21 THE ROLE OF YOGA IN THE MANAGEMENT OF BLADDER PAIN SYNDROME: A SINGLE-ARM PILOT STUDY. BACKGROUND: BLADDER PAIN SYNDROME (BPS) IS A DEVASTATING UROLOGIC CONDITION CHARACTERIZED BY IRRITATIVE BLADDER SYMPTOMS, PELVIC PAIN, AND DYSPAREUNIA. FIRST-LINE TREATMENT INCLUDES DIETARY, SELF-CARE AND BEHAVIORAL MODIFICATIONS. THE ANCIENT PRACTICE OF YOGA IS WELL SUITED TO TREAT BPS, BUT EVIDENCE IS LACKING ON ITS USE. AIMS: TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF AN INTEGRATED YOGA MODULE ON BPS OUTCOMES AS MEASURED BY SELF-REPORTED QUESTIONNAIRES FROM BASELINE TO 3 MONTHS AFTER THERAPY. METHODS AND MATERIALS: THIS WAS A PROSPECTIVE SINGLE-ARM STUDY OF 8 PATIENTS WHO UNDERWENT 3 MONTHS OF INTEGRATED YOGA THERAPY. THE TREATMENT MODULE WAS PERFORMED 3 TO 4 TIMES WEEKLY AT HOME WITH 1 SESSION PERFORMED WEEKLY IN-OFFICE DURING THE FIRST MONTH TO ENSURE PROPER PERFORMANCE OF POSTURES. PATIENTS COMPLETED QUESTIONNAIRES (PELVIC PAIN AND URGENCY/FREQUENCY PATIENT SYMPTOM SCALE [PUF], PELVIC FLOOR IMPACT QUESTIONNAIRE - SHORT FORM 7 [PFIQ-7], SHORT FORM 36 QUESTIONNAIRE [SF-36], PITTSBURGH SLEEP QUALITY INDEX [PSQI]) AT BASELINE AND 3 MONTHS, INCLUDING PATIENT GLOBAL IMPRESSION OF IMPROVEMENT (PGI-I) AT THE 3-MONTH FOLLOW-UP VISIT. VOIDING DIARIES WERE ALSO REQUESTED AT BASELINE AND AT THE 3-MONTH ASSESSMENT. RESULTS: THERE WAS A TREND TOWARD IMPROVEMENT REGARDING PATIENTS' RESPONSES TO ALL QUESTIONNAIRES 3 MONTHS AFTER YOGA THERAPY, WITH THE ONLY STATISTICALLY SIGNIFICANT IMPROVEMENTS NOTED IN SOCIAL FUNCTION AND PAIN COMPONENTS OF THE SF-36. THERE WERE NO SIGNIFICANT CHANGES NOTED ON THE VOIDING DIARIES EXCEPT A NON-STATISTICALLY SIGNIFICANT TREND TOWARD INCREASED VOIDED VOLUMES. PATIENTS RATED THEIR EXPERIENCES WITH YOGA THERAPY POSITIVELY. CONCLUSIONS: YOGA THERAPY FOR BPS SHOWED EVIDENCE OF BENEFIT FOR IMPROVING BOTHERSOME BLADDER SYMPTOMS, PAIN AND VOIDING. A RANDOMIZED CONTROLLED TRIAL WILL FOLLOW TO INVESTIGATE THE EFFICACY OF THIS YOGA MODULE AGAINST A CONTROL GROUP. 2020 5 2880 18 YOGA: A BIOBEHAVIORAL APPROACH TO REDUCE SYMPTOM DISTRESS IN WOMEN WITH URGE URINARY INCONTINENCE. URGE URINARY INCONTINENCE IS A DEBILITATING CHRONIC CONDITION THAT POSES CHALLENGES FOR AFFECTED WOMEN AND THE CLINICIANS WHO CARE FOR THEM. MULTICOMPONENT BEHAVIORAL THERAPIES HAVE SHOWN PROMISE IN ALLOWING WOMEN TO MANAGE THEIR SYMPTOMS. NEW EVIDENCE SUGGESTS AN UNDERLYING PATHOPHYSIOLOGIC INFLAMMATORY PROCESS FOR URGE URINARY INCONTINENCE, AND COMPLEMENTARY THERAPIES THAT ADDRESS THE PSYCHONEUROIMMUNOLOGY COMPONENT MAY IMPROVE THE HEALTH AND QUALITY OF LIFE FOR THE MILLIONS OF WOMEN WITH THIS CONDITION. YOGA, A MIND-BODY THERAPY, HAS BEEN SHOWN TO REDUCE INFLAMMATION AND MAY HELP IMPROVE SYMPTOMS OF URGE URINARY INCONTINENCE. MORE RESEARCH IS NECESSARY TO DEMONSTRATE THE EFFECTIVENESS OF YOGA TO REDUCE URGE URINARY INCONTINENCE SYMPTOM BURDEN AND IMPROVE QUALITY OF LIFE. 2014 6 2832 24 YOGA'S BIOPHYSIOLOGICAL EFFECTS ON LOWER URINARY TRACT SYMPTOMS: A SCOPING REVIEW. BACKGROUND AND OBJECTIVES: YOGA IS A MIND AND BODY PRACTICE THAT INCLUDES RELAXATION, MEDITATION, BREATHING EXERCISES, AND BODY POSTURES. IT CAN BE EFFECTIVE IN ENHANCING THE FUNCTIONING OF SEVERAL BODY SYSTEMS, INCLUDING THE LOWER URINARY TRACT. NORMAL LOWER URINARY TRACT FUNCTIONING DEPENDS IN PART ON THE COORDINATION OF THE BLADDER, URETHRA, PELVIC FLOOR AND OTHER MUSCLES, AND THE NERVES THAT CONTROL THEM. LOWER URINARY TRACT DYSFUNCTION CAN LEAD TO SYMPTOMS, THAT IS, STRESS URINARY INCONTINENCE (UI), URINARY FREQUENCY, NOCTURIA, URINARY URGENCY WITH AND WITHOUT INCONTINENCE, AND MIXED UI. RECENT EVIDENCE SUGGESTS THAT YOGA CAN IMPROVE LOWER URINARY TRACT SYMPTOMS (LUTS). THUS, WE PERFORMED A SCOPING REVIEW OF THE LITERATURE WITH REGARD TO THE EVIDENCE FOR THE EFFECTS OF YOGA ON LUTS AND FACTORS THAT MAY MEDIATE YOGA'S EFFECTS ON LUTS WITH THE GOAL TO IDENTIFY GAPS IN KNOWLEDGE REGARDING THE RELATIONSHIP BETWEEN YOGA PRACTICE AND LUTS. METHODS: THE AUTHORS EMPLOYED THE PRISMA EXTENSION FOR SCOPING REVIEWS (PRISMA-SCR) METHODOLOGICAL APPROACH, PROPOSED BY TRICCO ET AL., BY SEARCHING THE ELECTRONIC DATABASES, PUBMED, EMBASE, AND PSYCINFO, FOR ARTICLES USING THE FOLLOWING KEYWORDS: YOGA, URINARY INCONTINENCE, URINARY TRACT, BLADDER, AND URETHRA. WE ASSESSED THE QUALITY OF THE STUDIES USING THE JOANNA BRIGGS INSTITUTE CRITICAL APPRAISAL CHECKLIST. RESULTS: OF THE 172 ARTICLES WE FOUND, 8 ARTICLES MET THE INCLUSION CRITERIA AND WERE REVIEWED. WE FOUND THAT, DESPITE THE USE OF DIFFERENT PROTOCOLS, YOGA MAY REDUCE CERTAIN LUTS BY INCREASING THE STRENGTH OF PELVIC FLOOR MUSCLE AND/OR REGULATING THE AUTONOMIC NERVOUS SYSTEM AND ACTIVATING THE CENTRAL NERVOUS SYSTEM. CONCLUSIONS: YOGA IS A NONINVASIVE PRACTICE THAT MAY IMPROVE SOME LUTS. RIGOROUS STUDIES ARE NEEDED TO DETERMINE THE SPECIFIC MECHANISMS THROUGH WHICH YOGA MAY AFFECT LUTS. 2019 7 2300 43 THERAPEUTIC YOGA: SYMPTOM MANAGEMENT FOR MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS THE MOST COMMON AUTOIMMUNE INFLAMMATORY DEMYELINATING DISEASE OF THE CENTRAL NERVOUS SYSTEM, AFFECTING OVER 2.3 MILLION PEOPLE WORLDWIDE. ACCORDING TO THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, THE AGE OF DISEASE ONSET IS TYPICALLY BETWEEN 20 AND 40 YEARS, WITH A HIGHER INCIDENCE IN WOMEN. INDIVIDUALS WITH MS EXPERIENCE A WIDE RANGE OF SYMPTOMS, INCLUDING DECLINING PHYSICAL, EMOTIONAL, AND PSYCHOLOGICAL SYMPTOMS (E.G., FATIGUE, IMBALANCE, SPASTICITY, CHRONIC PAIN, COGNITIVE IMPAIRMENT, BLADDER AND BOWEL DYSFUNCTION, VISUAL AND SPEECH IMPAIRMENTS, DEPRESSION, SENSORY DISTURBANCE, AND MOBILITY IMPAIRMENT). TO DATE, BOTH THE CAUSE OF AND CURE FOR MS REMAIN UNKNOWN. IN RECENT YEARS, MORE INDIVIDUALS WITH MS HAVE BEEN PURSUING ALTERNATIVE METHODS OF TREATMENT TO MANAGE SYMPTOMS OF THE DISEASE, INCLUDING MIND-BODY THERAPIES SUCH AS YOGA, MEDITATION, BREATHING, AND RELAXATION TECHNIQUES. IT HAS BEEN SUGGESTED THAT THE PRACTICE OF YOGA MAY BE A SAFE AND EFFECTIVE WAY OF MANAGING SYMPTOMS OF MS. THEREFORE, THE PURPOSE OF THIS PAPER IS TO SUMMARIZE THE MOST RELEVANT LITERATURE ON EXERCISE AND MIND-BODY MODALITIES TO TREAT MS SYMPTOMS AND, MORE SPECIFICALLY, THE BENEFITS AND POTENTIAL ROLE OF YOGA AS AN ALTERNATIVE TREATMENT OF SYMPTOM MANAGEMENT FOR INDIVIDUALS WITH MS. THE ARTICLE ALSO DISCUSSES FUTURE DIRECTIONS FOR RESEARCH. 2015 8 73 24 A GROUP-BASED YOGA PROGRAM FOR URINARY INCONTINENCE IN AMBULATORY WOMEN: FEASIBILITY, TOLERABILITY, AND CHANGE IN INCONTINENCE FREQUENCY OVER 3 MONTHS IN A SINGLE-CENTER RANDOMIZED TRIAL. BACKGROUND: BECAUSE OF THE LIMITATIONS OF EXISTING CLINICAL TREATMENTS FOR URINARY INCONTINENCE, MANY WOMEN WITH INCONTINENCE ARE INTERESTED IN COMPLEMENTARY STRATEGIES FOR MANAGING THEIR SYMPTOMS. YOGA HAS BEEN RECOMMENDED AS A BEHAVIORAL SELF-MANAGEMENT STRATEGY FOR INCONTINENCE, BUT EVIDENCE OF ITS FEASIBILITY, TOLERABILITY, AND EFFICACY IS LACKING. OBJECTIVE: TO EVALUATE THE FEASIBILITY AND TOLERABILITY OF A GROUP-BASED THERAPEUTIC YOGA PROGRAM FOR AMBULATORY MIDDLE-AGED AND OLDER WOMEN WITH INCONTINENCE, AND TO EXAMINE PRELIMINARY CHANGES IN INCONTINENCE FREQUENCY AS THE PRIMARY EFFICACY OUTCOME AFTER 3 MONTHS. MATERIALS AND METHODS: AMBULATORY WOMEN AGED 50 YEARS OR OLDER WHO REPORTED AT LEAST DAILY STRESS-, URGENCY-, OR MIXED-TYPE INCONTINENCE, WERE NOT ALREADY ENGAGED IN YOGA, AND WERE WILLING TO TEMPORARILY FORGO CLINICAL INCONTINENCE TREATMENTS WERE RECRUITED INTO A RANDOMIZED TRIAL IN THE SAN FRANCISCO BAY AREA. WOMEN WERE RANDOMLY ASSIGNED TO TAKE PART IN A PROGRAM OF TWICE-WEEKLY GROUP CLASSES AND ONCE-WEEKLY HOME PRACTICE FOCUSED ON IYENGAR-BASED YOGA TECHNIQUES SELECTED BY AN EXPERT YOGA PANEL (YOGA GROUP), OR A NONSPECIFIC MUSCLE STRETCHING AND STRENGTHENING PROGRAM DESIGNED TO PROVIDE A RIGOROUS TIME-AND-ATTENTION CONTROL (CONTROL GROUP) FOR 3 MONTHS. ALL PARTICIPANTS ALSO RECEIVED WRITTEN, EVIDENCE-BASED INFORMATION ABOUT BEHAVIORAL INCONTINENCE SELF-MANAGEMENT TECHNIQUES (PELVIC FLOOR EXERCISES, BLADDER TRAINING) CONSISTENT WITH USUAL FIRST-LINE CARE. INCONTINENCE FREQUENCY AND TYPE WERE ASSESSED BY VALIDATED VOIDING DIARIES. ANALYSIS OF COVARIANCE MODELS EXAMINED WITHIN- AND BETWEEN-GROUP CHANGES IN INCONTINENCE FREQUENCY AS THE PRIMARY EFFICACY OUTCOME OVER 3 MONTHS. RESULTS: OF THE 56 WOMEN RANDOMIZED (28 TO YOGA, 28 TO CONTROL), THE MEAN AGE WAS 65.4 (+/-8.1) YEARS (RANGE, 55-83 YEARS), THE MEAN BASELINE INCONTINENCE FREQUENCY WAS 3.5 (+/-2.0) EPISODES/D, AND 37 WOMEN (66%) HAD URGENCY-PREDOMINANT INCONTINENCE. A TOTAL OF 50 WOMEN COMPLETED THEIR ASSIGNED 3-MONTH INTERVENTION PROGRAM (89%), INCLUDING 27 IN THE YOGA AND 23 IN THE CONTROL GROUP (P = .19). OF THOSE, 24 (89%) IN THE YOGA AND 20 (87%) IN THE CONTROL GROUP ATTENDED AT LEAST 80% OF GROUP CLASSES. OVER 3 MONTHS, TOTAL INCONTINENCE FREQUENCY DECREASED BY AN AVERAGE OF 76% FROM BASELINE IN THE YOGA AND 56% IN THE CONTROL GROUP (P = .07 FOR BETWEEN-GROUP DIFFERENCE). STRESS INCONTINENCE FREQUENCY ALSO DECREASED BY AN AVERAGE OF 61% IN THE YOGA GROUP AND 35% IN CONTROLS (P = .045 FOR BETWEEN-GROUP DIFFERENCE), BUT CHANGES IN URGENCY INCONTINENCE FREQUENCY DID NOT DIFFER SIGNIFICANTLY BETWEEN GROUPS. A TOTAL OF 48 NONSERIOUS ADVERSE EVENTS WERE REPORTED, INCLUDING 23 IN THE YOGA AND 25 IN THE CONTROL GROUP, BUT NONE WERE DIRECTLY ATTRIBUTABLE TO YOGA OR CONTROL PROGRAM PRACTICE. CONCLUSION: FINDINGS DEMONSTRATE THE FEASIBILITY OF RECRUITING AND RETAINING INCONTINENT WOMEN ACROSS THE AGING SPECTRUM INTO A THERAPEUTIC YOGA PROGRAM, AND PROVIDE PRELIMINARY EVIDENCE OF REDUCTION IN TOTAL AND STRESS-TYPE INCONTINENCE FREQUENCY AFTER 3 MONTHS OF YOGA PRACTICE. WHEN TAUGHT WITH ATTENTION TO WOMEN'S CLINICAL NEEDS, YOGA MAY OFFER A POTENTIAL COMMUNITY-BASED BEHAVIORAL SELF-MANAGEMENT STRATEGY FOR INCONTINENCE TO ENHANCE CLINICAL TREATMENT, ALTHOUGH FUTURE RESEARCH SHOULD ASSESS WHETHER YOGA OFFERS UNIQUE BENEFITS FOR INCONTINENCE ABOVE AND BEYOND OTHER PHYSICAL ACTIVITY-BASED INTERVENTIONS. 2019 9 528 18 COMPARISON OF MINDFULNESS-BASED STRESS REDUCTION VERSUS YOGA ON URINARY URGE INCONTINENCE: A RANDOMIZED PILOT STUDY. WITH 6-MONTH AND 1-YEAR FOLLOW-UP VISITS. OBJECTIVES: THE OBJECTIVE OF THIS STUDY IS TO COMPARE THE EFFECTS OF MINDFULNESS-BASED STRESS REDUCTION (MBSR) VERSUS YOGA ON URINARY URGE INCONTINENCE (UI) AT 8 WEEKS, 6 MONTHS, AND 1 YEAR AFTER BEGINNING AN 8-WEEK PROGRAM. MATERIALS AND METHODS: PARTICIPANTS IN THIS PROSPECTIVE RANDOMIZED SINGLE-MASKED PILOT STUDY WERE WOMEN AGED 18 YEARS OR OLDER WITH URGE-PREDOMINANT INCONTINENCE, 5 OR MORE UI EPISODES (UIES) ON A 3-DAY VOIDING DIARY, AND NO RECENT ANTICHOLINERGIC USE. WOMEN WERE RANDOMIZED TO MBSR OR YOGA. THE PRIMARY OUTCOME WAS THE PERCENT CHANGE OF UIE. RESULTS: OF 30 ENROLLEES (15 IN MBSR, 15 IN YOGA), 24 COMPLETED AT LEAST 5 OF 8 SESSIONS (13 IN MBSR AND 11 IN YOGA). TWENTY AND 21 WOMEN COMPLETED THE 6-MONTH AND 12-MONTH FOLLOW-UP VISITS, RESPECTIVELY. AT 8 WEEKS, 6 MONTHS, AND 12 MONTHS, THE MEDIAN PERCENT CHANGE FROM THE BASELINE IN UIE ON THE INTENTION-TO-TREAT ANALYSIS WAS GREATER FOR THE MBSR GROUP (-55.6, -71.4, AND -66.7, RESPECTIVELY) COMPARED WITH THAT FOR THE YOGA GROUP (-33.3, -11.8, AND -16.7, RESPECTIVELY), WITH P VALUES RANGING FROM 0.01 TO 0.08. ON INTENTION-TO-TREAT ANALYSIS, THE MEDIAN PERCENT CHANGE IN THE OVERACTIVE BLADDER SYMPTOM AND QUALITY OF LIFE-SHORT FORM AND THE HEALTH-RELATED QUALITY OF LIFE WAS GREATER AT EACH TIME POINT FOR MBSR THAN FOR YOGA BUT WAS STATISTICALLY SIGNIFICANT ONLY AT 8 WEEKS (P = 0.003 AND 0.02, RESPECTIVELY). AS PER PROTOCOL ANALYSIS, AT 8 WEEKS, 6/13 AND 0/11 WOMEN IN MBSR AND YOGA, RESPECTIVELY, REPORTED THEY WERE VERY MUCH OR MUCH BETTER (P = 0.02), WHEREAS AT 1 YEAR, 6/12 AND 1/9 WOMEN IN MBSR AND YOGA, RESPECTIVELY, DID SO (P = 0.16). DISCUSSION: THESE RESULTS SUPPORT LARGER SCALE TRIALS TO EVALUATE MBSR, WHICH SEEMS TO BE A PROMISING TREATMENT OF UI. 2014 10 498 19 COMBINED PELVIC MUSCLE EXERCISE AND YOGA PROGRAM FOR URINARY INCONTINENCE IN MIDDLE-AGED WOMEN. AIM: URINARY INCONTINENCE IS A MAJOR HEALTH PROBLEM AMONG MIDDLE-AGED WOMEN. PELVIC MUSCLE EXERCISE IS ONE OF THE PRIMARY INTERVENTIONS, BUT DIFFICULTY PERFORMING THIS EXERCISE HAS LED RESEARCHERS TO SEEK ALTERNATIVE OR CONJUNCTIVE EXERCISE. THIS STUDY AIMED TO EXAMINE THE EFFECT OF A COMBINED PELVIC MUSCLE EXERCISE AND YOGA INTERVENTION PROGRAM ON URINARY INCONTINENCE. METHODS: A SINGLE GROUP PRE-/POST-TEST DESIGN WAS USED. SUBJECTS WERE RECRUITED FROM A COMMUNITY HEALTH CENTER IN SEOUL, KOREA, AND A QUESTIONNAIRE SURVEY WAS CONDUCTED. FIFTY-FIVE WOMEN PARTICIPATED IN THE FIRST DAY OF THE PROGRAM, 34 OF WHOM COMPLETED THE 8 WEEK, TWICE WEEKLY INTERVENTION PROGRAM. URINARY INCONTINENCE WAS MEASURED BY FIVE DOMAINS OF URINARY TRACT SYMPTOMS: FILLING FACTOR, VOIDING FACTOR, INCONTINENCE FACTOR, SEXUAL FUNCTION, AND QUALITY OF LIFE. ALSO MEASURED WERE ATTITUDE TOWARD PELVIC MUSCLE EXERCISE AND PELVIC MUSCLE STRENGTH. RESULTS: SIGNIFICANT IMPROVEMENTS WERE FOUND IN ATTITUDE TOWARD PELVIC MUSCLE EXERCISE, PELVIC MUSCLE STRENGTH, AND INCONTINENCE FACTOR. DAILY PERFORMANCE OF PELVIC MUSCLE EXERCISE WAS POSITIVELY CORRELATED WITH IMPROVED INCONTINENCE FACTOR AND WITH QUALITY OF LIFE RELATED TO URINARY TRACT SYMPTOMS. CONCLUSION: A COMBINED PELVIC MUSCLE EXERCISE AND YOGA PROGRAM WAS EFFECTIVE FOR IMPROVING OVERALL URINARY INCONTINENCE IN COMMUNITY HEALTH CENTER ATTENDEES IN KOREA. FURTHER STUDY IS NEEDED WITH A CONTROL GROUP, DIFFERENT POPULATIONS, AND A LONGER INTERVENTION PERIOD. 2015 11 74 17 A GROUP-BASED YOGA THERAPY INTERVENTION FOR URINARY INCONTINENCE IN WOMEN: A PILOT RANDOMIZED TRIAL. OBJECTIVE: THE AIM OF THIS STUDY IS TO EXAMINE THE FEASIBILITY, EFFICACY, AND SAFETY OF A GROUP-BASED YOGA THERAPY INTERVENTION FOR MIDDLE-AGED AND OLDER WOMEN WITH URINARY INCONTINENCE. METHODS: WE CONDUCTED A PILOT RANDOMIZED TRIAL OF AMBULATORY WOMEN AGED 40 YEARS AND OLDER WITH STRESS, URGENCY, OR MIXED-TYPE INCONTINENCE. WOMEN WERE RANDOMIZED TO A 6-WEEK YOGA THERAPY PROGRAM (N = 10) CONSISTING OF TWICE WEEKLY GROUP CLASSES AND ONCE WEEKLY HOME PRACTICE OR A WAIT-LIST CONTROL GROUP (N = 9). ALL PARTICIPANTS ALSO RECEIVED WRITTEN PAMPHLETS ABOUT STANDARD BEHAVIORAL SELF-MANAGEMENT STRATEGIES FOR INCONTINENCE. CHANGES IN INCONTINENCE WERE ASSESSED WITH 7-DAY VOIDING DIARIES. RESULTS: THE MEAN (SD) AGE WAS 61.4 (8.2) YEARS, AND THE MEAN BASELINE FREQUENCY OF INCONTINENCE WAS 2.5 (1.3) EPISODES/D. AFTER 6 WEEKS, THE TOTAL INCONTINENCE FREQUENCY DECREASED BY 70% (1.8 [0.9] FEWER EPISODES/D) IN THE YOGA THERAPY VERSUS 13% (0.3 [1.7] FEWER EPISODES/D) IN THE CONTROL GROUP (P = 0.049). PARTICIPANTS IN THE YOGA THERAPY GROUP ALSO REPORTED AN AVERAGE OF 71% DECREASE IN STRESS INCONTINENCE FREQUENCY (0.7 [0.8] FEWER EPISODES/D) COMPARED WITH A 25% INCREASE IN CONTROLS (0.2 [1.1] MORE EPISODES/D) (P = 0.039). NO SIGNIFICANT DIFFERENCES IN REDUCTION IN URGENCY INCONTINENCE WERE DETECTED BETWEEN THE YOGA THERAPY VERSUS CONTROL GROUPS (1.0 [1.0] VERSUS 0.5 [0.5] FEWER EPISODES/D; P = 0.20). ALL WOMEN STARTING THE YOGA THERAPY PROGRAM COMPLETED AT LEAST 90% OF THE GROUP CLASSES AND PRACTICE SESSIONS. TWO PARTICIPANTS IN EACH GROUP REPORTED ADVERSE EVENTS UNRELATED TO THE INTERVENTION. CONCLUSIONS: FINDINGS PROVIDE PRELIMINARY EVIDENCE TO SUPPORT THE FEASIBILITY, EFFICACY, AND SAFETY OF A GROUP-BASED YOGA THERAPY INTERVENTION TO IMPROVE URINARY INCONTINENCE IN WOMEN. 2014 12 2460 36 YOGA AS A METHOD OF SYMPTOM MANAGEMENT IN MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS AN IMMUNE-MEDIATED PROCESS IN WHICH THE BODY'S IMMUNE SYSTEM DAMAGES MYELIN IN THE CENTRAL NERVOUS SYSTEM (CNS). THE ONSET OF THIS DISORDER TYPICALLY OCCURS IN YOUNG ADULTS, AND IT IS MORE COMMON AMONG WOMEN. CURRENTLY, THERE IS NO CURE AND THE LONG-TERM DISEASE PROGRESSION MAKES SYMPTOMATIC MANAGEMENT CRITICAL FOR MAINTAINING QUALITY OF LIFE. SEVERAL PHARMACOTHERAPEUTIC AGENTS ARE APPROVED FOR TREATMENT, BUT MANY PATIENTS SEEK COMPLEMENTARY AND ALTERNATIVE INTERVENTIONS. REVIEWS HAVE BEEN CONDUCTED REGARDING BROAD TOPICS SUCH AS MINDFULNESS-BASED INTERVENTIONS FOR PEOPLE DIAGNOSED WITH MS AND THE IMPACT OF YOGA ON A RANGE OF NEUROLOGICAL DISORDERS. THE OBJECTIVE OF THE PRESENT REVIEW IS TO EXAMINE THE POTENTIAL BENEFITS OF YOGA FOR INDIVIDUALS WITH MS AND ADDRESS ITS USE IN MANAGING SYMPTOMS INCLUDING PAIN, MENTAL HEALTH, FATIGUE, SPASTICITY, BALANCE, BLADDER CONTROL, AND SEXUAL FUNCTION. 2015 13 2637 17 YOGA FOR TREATMENT OF URINARY INCONTINENCE IN WOMEN. THIS IS A PROTOCOL FOR A COCHRANE REVIEW (INTERVENTION). THE OBJECTIVES ARE AS FOLLOWS: TO ASSESS THE EFFECTIVENESS AND SAFETY OF YOGA FOR TREATMENT OF URINARY INCONTINENCE IN WOMEN, COMPARED TO NO SPECIFIC TREATMENT, TO ANOTHER ACTIVE TREATMENT, OR TO AN ACTIVE TREATMENT WITHOUT ADJUVANT YOGA, WITH A FOCUS ON PATIENT SYMPTOMS AND QUALITY OF LIFE. 2017 14 2644 22 YOGA FOR WOMEN WITH URGENCY URINARY INCONTINENCE: A PILOT STUDY. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE THE FEASIBILITY OF A GENTLE YOGA PROGRAM FOR WOMEN WITH URGENCY URINARY INCONTINENCE (UUI). ALSO, THESE PRELIMINARY DATA CAN EVALUATE IF YOGA IMPROVES SYMPTOM BURDEN, QUALITY OF LIFE, AND INFLAMMATORY BIOMARKERS FOR WOMEN WITH UUI. METHODS: THIS PROSPECTIVE NONRANDOMIZED SINGLE-ARM PILOT STUDY EVALUATED THE EFFECTIVENESS OF A TWICE-WEEKLY, 8-WEEK GENTLE YOGA INTERVENTION TO REDUCE UUI SYMPTOM BURDEN. CHANGES IN SYMPTOM BURDEN WERE MEASURED USING THE PELVIC FLOOR DISTRESS INVENTORY 20. SECONDARY MEASURES INCLUDED QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, SLEEP, STRESS, ANXIETY, AND INFLAMMATORY BIOMARKERS. OUTCOMES WERE EVALUATED WITH PAIRED T TESTING. RESULTS: TWELVE WOMEN COMPLETED THE YOGA INTERVENTION WITH NO ADVERSE OUTCOMES NOTED. URGENCY SYMPTOM BURDEN WAS SIGNIFICANTLY IMPROVED AFTER THE INTERVENTION (P = 0.01), AND WOMEN REPORTED AN INCREASE IN QUALITY OF LIFE (P = 0.04) AFTER THE YOGA INTERVENTION. FOLLOWING THE YOGA INTERVENTION, THE MAJORITY OF WOMEN REPORTED SYMPTOMS AS "MUCH BETTER" (N = 4 [33%]) AND "A LITTLE BETTER" (N = 5 [42%]), WITH 3 WOMEN (25%) REPORTING "NO CHANGE." WOMEN ALSO REPORTED SIGNIFICANT REDUCTION IN DEPRESSIVE SYMPTOMS (P = 0.03) AND BETTER QUALITY OF SLEEP (P = 0.03). NO SIGNIFICANT CHANGES WERE FOUND IN ANXIETY OR STRESS PERCEPTION. PLASMA LEVELS OF THE INFLAMMATORY BIOMARKER TUMOR NECROSIS FACTOR ALPHA WERE REDUCED AFTER YOGA INTERVENTION (P = 0.009); HOWEVER, NO SIGNIFICANT POSTYOGA CHANGES WERE FOUND FOR INTERLEUKIN 6 OR C-REACTIVE PROTEIN. CONCLUSIONS: THIS STUDY PROVIDES PRELIMINARY EVIDENCE THAT YOGA IS A FEASIBLE COMPLEMENTARY THERAPY THAT REDUCES INCONTINENCE SYMPTOM BURDEN, ALONG WITH IMPROVING QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, AND SLEEP QUALITY. ADDITIONALLY, YOGA MAY LOWER INFLAMMATORY BIOMARKERS ASSOCIATED WITH INCONTINENCE. 2021 15 2543 38 YOGA FOR ASTHMA. BACKGROUND: ASTHMA IS A COMMON CHRONIC INFLAMMATORY DISORDER AFFECTING ABOUT 300 MILLION PEOPLE WORLDWIDE. AS A HOLISTIC THERAPY, YOGA HAS THE POTENTIAL TO RELIEVE BOTH THE PHYSICAL AND PSYCHOLOGICAL SUFFERING OF PEOPLE WITH ASTHMA, AND ITS POPULARITY HAS EXPANDED GLOBALLY. A NUMBER OF CLINICAL TRIALS HAVE BEEN CARRIED OUT TO EVALUATE THE EFFECTS OF YOGA PRACTICE, WITH INCONSISTENT RESULTS. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA IN PEOPLE WITH ASTHMA. SEARCH METHODS: WE SYSTEMATICALLY SEARCHED THE COCHRANE AIRWAYS GROUP REGISTER OF TRIALS, WHICH IS DERIVED FROM SYSTEMATIC SEARCHES OF BIBLIOGRAPHIC DATABASES INCLUDING THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED, AND PSYCINFO, AND HANDSEARCHING OF RESPIRATORY JOURNALS AND MEETING ABSTRACTS. WE ALSO SEARCHED PEDRO. WE SEARCHED CLINICALTRIALS.GOV AND THE WHO ICTRP SEARCH PORTAL. WE SEARCHED ALL DATABASES FROM THEIR INCEPTION TO 22 JULY 2015, AND USED NO RESTRICTION ON LANGUAGE OF PUBLICATION. WE CHECKED THE REFERENCE LISTS OF ELIGIBLE STUDIES AND RELEVANT REVIEW ARTICLES FOR ADDITIONAL STUDIES. WE ATTEMPTED TO CONTACT INVESTIGATORS OF ELIGIBLE STUDIES AND EXPERTS IN THE FIELD TO LEARN OF OTHER PUBLISHED AND UNPUBLISHED STUDIES. SELECTION CRITERIA: WE INCLUDED RANDOMISED CONTROLLED TRIALS (RCTS) THAT COMPARED YOGA WITH USUAL CARE (OR NO INTERVENTION) OR SHAM INTERVENTION IN PEOPLE WITH ASTHMA AND REPORTED AT LEAST ONE OF THE FOLLOWING OUTCOMES: QUALITY OF LIFE, ASTHMA SYMPTOM SCORE, ASTHMA CONTROL, LUNG FUNCTION MEASURES, ASTHMA MEDICATION USAGE, AND ADVERSE EVENTS. DATA COLLECTION AND ANALYSIS: WE EXTRACTED BIBLIOGRAPHIC INFORMATION, CHARACTERISTICS OF PARTICIPANTS, CHARACTERISTICS OF INTERVENTIONS AND CONTROLS, CHARACTERISTICS OF METHODOLOGY, AND RESULTS FOR THE OUTCOMES OF OUR INTEREST FROM ELIGIBLE STUDIES. FOR CONTINUOUS OUTCOMES, WE USED MEAN DIFFERENCE (MD) WITH 95% CONFIDENCE INTERVAL (CI) TO DENOTE THE TREATMENT EFFECTS, IF THE OUTCOMES WERE MEASURED BY THE SAME SCALE ACROSS STUDIES. ALTERNATIVELY, IF THE OUTCOMES WERE MEASURED BY DIFFERENT SCALES ACROSS STUDIES, WE USED STANDARDISED MEAN DIFFERENCE (SMD) WITH 95% CI. FOR DICHOTOMOUS OUTCOMES, WE USED RISK RATIO (RR) WITH 95% CI TO MEASURE THE TREATMENT EFFECTS. WE PERFORMED META-ANALYSIS WITH REVIEW MANAGER 5.3. WE USED THE FIXED-EFFECT MODEL TO POOL THE DATA, UNLESS THERE WAS SUBSTANTIAL HETEROGENEITY AMONG STUDIES, IN WHICH CASE WE USED THE RANDOM-EFFECTS MODEL INSTEAD. FOR OUTCOMES INAPPROPRIATE OR IMPOSSIBLE TO POOL QUANTITATIVELY, WE CONDUCTED A DESCRIPTIVE ANALYSIS AND SUMMARISED THE FINDINGS NARRATIVELY. MAIN RESULTS: WE INCLUDED 15 RCTS WITH A TOTAL OF 1048 PARTICIPANTS. MOST OF THE TRIALS WERE CONDUCTED IN INDIA, FOLLOWED BY EUROPE AND THE UNITED STATES. THE MAJORITY OF PARTICIPANTS WERE ADULTS OF BOTH SEXES WITH MILD TO MODERATE ASTHMA FOR SIX MONTHS TO MORE THAN 23 YEARS. FIVE STUDIES INCLUDED YOGA BREATHING ALONE, WHILE THE OTHER STUDIES ASSESSED YOGA INTERVENTIONS THAT INCLUDED BREATHING, POSTURE, AND MEDITATION. INTERVENTIONS LASTED FROM TWO WEEKS TO 54 MONTHS, FOR NO MORE THAN SIX MONTHS IN THE MAJORITY OF STUDIES. THE RISK OF BIAS WAS LOW ACROSS ALL DOMAINS IN ONE STUDY AND UNCLEAR OR HIGH IN AT LEAST ONE DOMAIN FOR THE REMAINDER.THERE WAS SOME EVIDENCE THAT YOGA MAY IMPROVE QUALITY OF LIFE (MD IN ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) SCORE PER ITEM 0.57 UNITS ON A 7-POINT SCALE, 95% CI 0.37 TO 0.77; 5 STUDIES; 375 PARTICIPANTS), IMPROVE SYMPTOMS (SMD 0.37, 95% CI 0.09 TO 0.65; 3 STUDIES; 243 PARTICIPANTS), AND REDUCE MEDICATION USAGE (RR 5.35, 95% CI 1.29 TO 22.11; 2 STUDIES) IN PEOPLE WITH ASTHMA. THE MD FOR AQLQ SCORE EXCEEDED THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) OF 0.5, BUT WHETHER THE MEAN CHANGES EXCEEDED THE MCID FOR ASTHMA SYMPTOMS IS UNCERTAIN DUE TO THE LACK OF AN ESTABLISHED MCID IN THE SEVERITY SCORES USED IN THE INCLUDED STUDIES. THE EFFECTS OF YOGA ON CHANGE FROM BASELINE FORCED EXPIRATORY VOLUME IN ONE SECOND (MD 0.04 LITRES, 95% CI -0.10 TO 0.19; 7 STUDIES; 340 PARTICIPANTS; I(2) = 68%) WERE NOT STATISTICALLY SIGNIFICANT. TWO STUDIES INDICATED IMPROVED ASTHMA CONTROL, BUT DUE TO VERY SIGNIFICANT HETEROGENEITY (I(2) = 98%) WE DID NOT POOL DATA. NO SERIOUS ADVERSE EVENTS ASSOCIATED WITH YOGA WERE REPORTED, BUT THE DATA ON THIS OUTCOME WAS LIMITED. AUTHORS' CONCLUSIONS: WE FOUND MODERATE-QUALITY EVIDENCE THAT YOGA PROBABLY LEADS TO SMALL IMPROVEMENTS IN QUALITY OF LIFE AND SYMPTOMS IN PEOPLE WITH ASTHMA. THERE IS MORE UNCERTAINTY ABOUT POTENTIAL ADVERSE EFFECTS OF YOGA AND ITS IMPACT ON LUNG FUNCTION AND MEDICATION USAGE. RCTS WITH A LARGE SAMPLE SIZE AND HIGH METHODOLOGICAL AND REPORTING QUALITY ARE NEEDED TO CONFIRM THE EFFECTS OF YOGA FOR ASTHMA. 2016 16 2432 21 YOGA AND PILATES COMPARED TO PELVIC FLOOR MUSCLE TRAINING FOR URINARY INCONTINENCE IN ELDERLY WOMEN: A RANDOMISED CONTROLLED PILOT TRIAL. BACKGROUND: AND PURPOSE: THERE IS LIMITED EVIDENCE FROM RANDOMISED CONTROLLED TRIALS (RCTS) REGARDING THE USE OF YOGA AND PILATES FOR THE MANAGEMENT OF URINARY INCONTINENCE (UI) IN WOMEN. THIS STUDY AIMS TO INVESTIGATE THE PRELIMINARY EFFECTS OF USING PILATES AND YOGA TO MANAGE UI. MATERIALS AND METHODS: AN ASSESSOR-BLINDED, PROSPECTIVE, THREE-ARM PARALLEL-GROUP RANDOMISED CONTROLLED PILOT TRIAL WAS CONDUCTED IN THREE ELDERLY CARE CENTRES IN HONG KONG. THIRTY WOMEN AGED 60 YEARS OR ABOVE WERE INCLUDED IN THE STUDY. STUDY CENTRES WERE RANDOMLY ASSIGNED TO EACH OF THE THREE INTERVENTIONS (YOGA, PILATES AND PELVIC FLOOR MUSCLE TRAINING [PFMT; STANDARD CARE CONTROL]). STUDY INTERVENTIONS WERE PROVIDED ONCE A WEEK FOR FOUR WEEKS, FOLLOWED BY UNSUPERVISED CD-GUIDED HOME EXERCISES FOR EIGHT WEEKS. OUTCOMES INCLUDED THE INTERNATIONAL CONSULTATION ON INCONTINENCE QUESTIONNAIRE-SHORT FORM (ICIQ-SF), 1-H PAD TEST, AND FEASIBILITY MEASURES SUCH AS ADHERENCE TO THE INTERVENTION PROGRAMME, RECRUITMENT AND RETENTION RATES AND SAFETY. OUTCOMES WERE ASSESSED AT BASELINE, 4 AND 12 WEEKS. STATISTICAL ANALYSIS WAS PERFORMED USING TWO-WAY REPEATED MEASURES ANALYSIS OF COVARIANCE. RESULTS: ALL THREE INTERVENTIONS DEMONSTRATED A STATISTICALLY SIGNIFICANT EFFECT ON ICIQ-SF SCORES FROM BASELINE TO WEEKS 4 AND 12. SIGNIFICANT EFFECTS IN UI WERE REPORTED FOR YOGA COMPARED WITH PILATES (MEAN: -2.93, 95% CI -5.35, -0.51; P = 0.02). CONCLUSION: YOGA POSES INTENDED TO ADDRESS THE PELVIC FLOOR AND CORE MUSCLES WERE FOUND TO HAVE SUPERIOR BENEFITS OVER PILATES EXERCISES IN TERMS OF IMPROVED CONTINENCE MEASURED WITH THE ICIQ-SF. 2022 17 1454 28 INFLUENCE OF SPORTS CLIMBING AND YOGA ON SPASTICITY, COGNITIVE FUNCTION, MOOD AND FATIGUE IN PATIENTS WITH MULTIPLE SCLEROSIS. OBJECTIVES: SPASTICITY, COGNITIVE IMPAIRMENT, DEPRESSION AND FATIGUE SIGNIFICANTLY REDUCE THE QUALITY OF LIFE IN MULTIPLE SCLEROSIS (MS) PATIENTS. TO FIND OUT WHETHER NONPHARMALOGICAL TREATMENT APPROACHES CAN REDUCE THESE SYMPTOMS WE INVESTIGATED EFFECTS OF SPORTS CLIMBING (SC) AND YOGA ON SPASTICITY, COGNITIVE IMPAIRMENT, MOOD CHANGE AND FATIGUE IN MS PATIENTS. SPORTS CLIMBING (SC) AND YOGA ARE AEROBIC PHYSICAL ACTIVITIES COMPRISED A SERIES OF STRETCHING TECHNIQUES, IMPLEMENTATION OF WHICH DEMANDS BODY CONTROL AND PLANNING OF COMPLEX MOVEMENTS. MATERIALS AND METHODS: 20 SUBJECTS WITH RELAPSING-REMITTING OR PROGRESSIVE MS, 26-50 YEARS OF AGE, WITH EDSS2 WERE ENROLLED IN A RANDOMIZED PROSPECTIVE STUDY. THE PARTICIPANTS WERE RANDOMLY DIVIDED INTO SC AND YOGA GROUP. WE EVALUATED SPASTICITY, COGNITIVE FUNCTION, MOOD AND FATIGUE BEFORE AND AFTER BOTH PROGRAMS, THAT LASTED 10 WEEKS, WITH STANDARDIZED ASSESSMENT METHODS. RESULTS: THERE WERE NO SIGNIFICANT IMPROVEMENTS IN SPASTICITY AFTER SC AND YOGA. IN THE SC GROUP WE FOUND A 25% REDUCTION (P=0.046) IN EDSSPYR. THERE WERE NO DIFFERENCES IN EXECUTIVE FUNCTION AFTER THE COMPLETION OF BOTH PROGRAMS. THERE WAS A 17% INCREASE IN SELECTIVE ATTENTION PERFORMANCE AFTER YOGA (P=0.005). SC REDUCED FATIGUE FOR 32.5% (P=0.015), WHILE YOGA HAD NO EFFECT. WE FOUND NO SIGNIFICANT IMPACT OF SC AND YOGA ON MOOD. CONCLUSIONS: YOGA AND SC MIGHT IMPROVE SOME OF THE MS SYMPTOMS AND SHOULD BE CONSIDERED IN THE FUTURE AS POSSIBLE COMPLEMENTARY TREATMENTS. 2010 18 2339 13 URINARY INCONTINENCE AMONG GROUP FITNESS INSTRUCTORS INCLUDING YOGA AND PILATES TEACHERS. AIMS: CONTROVERSIES EXIST ON THE ROLE OF PHYSICAL ACTIVITY ON URINARY INCONTINENCE (UI), AND SEARCH ON PUBMED REVEALED NO STUDIES ON UI IN FITNESS INSTRUCTORS. THE AIM OF THIS STUDY WAS TO INVESTIGATE THE PREVALENCE OF UI AMONG FEMALE GROUP FITNESS INSTRUCTORS, INCLUDING PILATES AND YOGA TEACHERS. METHODS: THIS WAS A CROSS-SECTIONAL STUDY OF 1,473 INSTRUCTORS REPRESENTING THREE OF THE LARGEST FITNESS COMPANIES RECRUITED FROM 59 FITNESS CENTERS IN NORWAY. THEY FILLED IN AN ONLINE SURVEY (QUESTBACK) ABOUT GENERAL HEALTH, EDUCATIONAL BACKGROUND, AND NUMBER OF HOURS TEACHING PER WEEK. PREVALENCE OF UI WAS EVALUATED BY THE INTERNATIONAL CONSENSUS ON INCONTINENCE QUESTIONNAIRE, SHORT FORM (ICIQ-UI SF). RESULTS: THREE OUT OF 152 MEN (2%) REPORTED UI. SIX HUNDRED EIGHTY-FIVE WOMEN, MEAN AGE 32.7 YEARS (RANGE 18-68) ANSWERED THE QUESTIONNAIRE. 26.3% OF ALL THE FEMALE INSTRUCTORS REPORTED TO HAVE UI, WITH 21.4% REPORTING LEAKAGE >/= ONCE A WEEK, 3.2% 2-3 TIMES/WEEK AND 1.7% >/= ONCE PER DAY. 24.4% REPORTED THE LEAKAGE TO BE SMALL TO MODERATE AND THE BOTHER SCORE WAS 4.6 (SD 2.4) OUT OF 21. 15.3% REPORTED LEAKAGE DURING PHYSICAL ACTIVITY AND 10.9% WHEN COUGHING/SNEEZING. 25.9% OF YOGA AND PILATES INSTRUCTORS REPORTED UI. CONCLUSIONS: THIS IS THE FIRST REPORT ON UI AMONG FITNESS INSTRUCTORS AND THE RESULTS INDICATE THAT UI IS PREVALENT AMONG FEMALE FITNESS INSTRUCTORS, INCLUDING YOGA AND PILATES TEACHERS. MORE INFORMATION ABOUT THIS TOPIC SEEMS TO BE IMPORTANT IN THE BASIC EDUCATION OF FITNESS INSTRUCTORS. 2011 19 714 27 EFFECT OF INTEGRATED YOGA ON NEUROGENIC BLADDER DYSFUNCTION IN PATIENTS WITH MULTIPLE SCLEROSIS-A PROSPECTIVE OBSERVATIONAL CASE SERIES. BACKGROUND: NEUROGENIC BLADDER DYSFUNCTION (NBD) IS A COMMON DISTRESSFUL SYMPTOM IN MULTIPLE SCLEROSIS (MS) AFFECTING QUALITY OF LIFE. YOGA HAS BEEN WIDELY USED IN TREATING VARIOUS SYMPTOMS OF PATIENTS WITH MS. OBJECTIVES: TO EVALUATE THE EFFECT OF INTEGRATED YOGA FOR NBD IN PATIENTS WITH MS AS AN ADJUNCT TO STANDARD MEDICAL CARE. DESIGN: THIS OPEN ARM, PRE-POST STUDY DESIGN ASSESSED THE OUTCOME MEASURES AT BASE LINE AND AFTER 21 DAYS OF INTEGRATED YOGA INTERVENTION. SETTING: STUDY WAS CONDUCTED AT THE CENTER FOR NEUROLOGICAL REHABILITATION AT KWA-KLINIK STIFT ROTTAL IN BAD GRIESBACH, GERMANY. ELEVEN MS PATIENTS WITH NBD (MEAN AGE 46.7+/-11.24 YEARS) WITH MEAN DURATION 17.2 YEARS VOLUNTEERED TO PARTICIPATE IN THE STUDY. INTERVENTIONS: INTEGRATED YOGA WHICH INCLUDES PREPARATORY YOGIC LOOSENING AND BREATHING PRACTICES, NADISHUDDI PRANAYAMA (ALTERNATE NOSTRIL BREATHING), MOOLA BANDHA (ANAL LOCK), KAPALBHATI (RAPID NOSTRIL BREATHING) AND DEEP RELAXATION TECHNIQUE WAS GIVEN FOR 2H PER DAY FOR CONTINUOUS 21 DAYS. OUTCOME MEASURES: ULTRASOUND SCANNING FOR POST VOID RESIDUAL URINE VOLUME (PVR), MICTURITION CHECK LIST (MCL), INCONTINENCE IMPACT QUESTIONNAIRE-7 (IIQ-7) ANDUROGENITAL DISTRESS INVENTORY-6 (UDI-6) WERE USED. RESULTS: PAIRED SAMPLE T-TEST SHOWED SIGNIFICANT IMPROVEMENT IN POST VOID RESIDUAL URINE (62.34%, P<0.05), SCORES ON MICTURITION FREQUENCY CHECKLIST (25%, P<0.05), INCONTINENCE IMPACT QUESTIONNAIRE-7 (32.77%, P<0.05) AND URO-GENITAL DISTRESS INVENTORY-6 (26.33%, P<0.05). CONCLUSION: THIS STUDY POINTS TO THE SAFETY AND EFFECTIVENESS OF INTEGRATED YOGA FOR BLADDER SYMPTOMS AS AN ADJUNCT TO STANDARD CARE IN MULTIPLE SCLEROSIS PATIENTS WITH NEUROGENIC BLADDER DYSFUNCTION IN GERMANY. FURTHER TRAILS ARE NECESSARY TO CONFIRM THESE FINDINGS. 2012 20 2783 23 YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT OF SYSTEMIC SCLEROSIS: A CASE SERIES. SYSTEMIC SCLEROSIS (SSC) IS AN AUTOIMMUNE DISORDER LEADING TO SIGNIFICANT DISABILITY AND LOSS OF QUALITY OF LIFE (QOL). YOGA HAS BECOME POPULAR IN RECENT TIMES FOR ITS POTENTIAL THERAPEUTIC BENEFITS. SINCE THERE ARE NO SCIENTIFIC REPORTS ON THE USE OF YOGA FOR SSC, WE PRESENT TWO FEMALE CASES (AGED 49 AND 29 RESPECTIVELY) OF LIMITED SSC (DURATION OF ILLNESS 4 AND 3 YEARS RESPECTIVELY) WHO UNDERWENT YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT IN A RESIDENTIAL SETTING FOR A PERIOD OF FIVE AND FOUR WEEKS, RESPECTIVELY. DURING THEIR STAY, THEY UNDERWENT A SPECIFICALLY DESIGNED YOGA MODULE. AFTER THEIR DISCHARGE, THEY WERE FOLLOWED-UP FOR FOUR WEEKS, DURING WHICH THEY WERE ASKED TO CONTINUE PRACTICING YOGA FOR 1 H EVERY DAY. BOTH OF THEM REPORTED A REDUCTION IN PAIN, STIFFNESS, SYMPTOM SCORES, AND IMPROVED QOL ON DISCHARGE AND AT THE FOLLOW-UP COMPARED TO THE VALUES ON ADMISSION. ERYTHROCYTE SEDIMENTATION RATE (ESR) AND C-REACTIVE PROTEIN (CRP), AS BIOMARKERS OF INFLAMMATION, REDUCED ON THE DISCHARGE WHEN COMPARED TO THE BASELINE. NO ADVERSE EVENTS WERE NOTED DURING THE STAY AND THE FOLLOW-UP. THUS, THE PRESENT CASE SERIES INDICATE A POSSIBLE BENEFICIAL ROLE OF YOGA AS AN ADJUNCT THERAPY TO CONVENTIONAL MANAGEMENT OF SSC. FURTHER STUDIES IN THE AREA ARE WARRANTED TO ASCERTAIN THE EFFICACY OF YOGA FOR SSC. 2021